新闻
Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
临床结果孤儿药
Dupixent® (dupilumab) Late-Breaking Positive Phase 3 Data in Chronic Spontaneous Urticaria to Be Presented at ACAAI
临床结果上市批准
2024-10-28
基石药业宣布British Journal of Clinical Pharmacology发表择捷美®群体药代动力学研究成果
免疫疗法抗体药物偶联物上市批准
2024-10-28
晚期癌症疾病控制率超80%!潜在“best-in-class”小分子抑制剂积极临床数据公布
临床结果临床研究
Analyses from Cognition’s Positive Phase 2 ‘SHINE’ Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease will be Presented in a Podium Presentation at CTAD
临床研究
2024-10-28
2024-10-28
治疗重症肌无力!荣昌生物“泰它西普”第三项适应症上市申请被纳入优先审评审批程序
优先审批免疫疗法突破性疗法孤儿药
2024-10-28
核酸药物上市批准
EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration
临床结果
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
临床结果引进/卖出孤儿药